{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:45:32Z","timestamp":1780577132274,"version":"3.54.1"},"reference-count":64,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Rep"],"DOI":"10.3892\/mmr.2022.12722","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:42:06Z","timestamp":1651214526000},"source":"Crossref","is-referenced-by-count":4,"title":["A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFN\u03b2 produces a synergistic activity in the reduction of lymphoma and mice survival enlargement"],"prefix":"10.3892","volume":"25","author":[{"given":"Adriana","family":"Quiroz-Reyes","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gonz\u00e1lez-Villarreal","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Department of Basic Sciences, University of Monterrey, Monterrey, Nuevo Le\u00f3n 66238, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herminia","family":"Mart\u00ednez-Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Said-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Salinas-Carmona","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lim\u00f3n-Flores","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Soto-Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Department of Histology, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Padilla-Rivas","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Montes De Oca-Luna","sequence":"additional","affiliation":[{"name":"Department of Histology, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Islas","sequence":"additional","affiliation":[{"name":"Department of Histology, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Garza-Trevi\u00f1o","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Le\u00f3n 64460, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"key20220527094434_b1-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/138161210789941847","article-title":"Recent advances in cancer: An Overview","volume":"16","author":"Urrutiocoechea","year":"2010","journal-title":"Curr Pharm Des"},{"key":"key20220527094434_b2-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus","volume":"326","author":"Herskovic","year":"1992","journal-title":"N Engl J Med"},{"key":"key20220527094434_b3-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3390\/ijms19071979","article-title":"Gold nanoparticles in diagnostics and therapeutics for human cancer","volume":"19","author":"Singh","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20220527094434_b4-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"20150207","DOI":"10.1259\/bjr.20150207","article-title":"Applications of nanoparticles for diagnosis and therapy of cancer","volume":"88","author":"Baetke","year":"2015","journal-title":"Br J Radiol"},{"key":"key20220527094434_b5-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"key20220527094434_b6-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Mol Med"},{"key":"key20220527094434_b7-mmr-25-06-12722","first-page":"139","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"176","author":"Ling","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"key20220527094434_b8-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/sj.bjc.6605952","article-title":"TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population","volume":"103","author":"Loebinger","year":"2010","journal-title":"Br J Cancer"},{"key":"key20220527094434_b9-mmr-25-06-12722","first-page":"6265","article-title":"Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model","volume":"15","author":"Liu","year":"2018","journal-title":"Oncol Lett"},{"key":"key20220527094434_b10-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"4054815","DOI":"10.1155\/2018\/4054815","article-title":"Viral and nonviral engineering of natural killer cells as emerging adoptive cancer immunotherapies","volume":"2018","author":"Matosevic","year":"2018","journal-title":"J Immunol Res"},{"key":"key20220527094434_b11-mmr-25-06-12722","first-page":"267","article-title":"Fibroblast precursors in normal and irradiated mouse hematopoietic organs","volume":"4","author":"Friedenstein","year":"1976","journal-title":"Exp Hematol"},{"key":"key20220527094434_b12-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"key20220527094434_b13-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/14653240410005366-1","article-title":"Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta","volume":"6","author":"Igura","year":"2004","journal-title":"Cytotherapy"},{"key":"key20220527094434_b14-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","article-title":"Mesenchymal stem cell homing: The devil is in the details","volume":"4","author":"Karp","year":"2009","journal-title":"Cell Stem Cell"},{"key":"key20220527094434_b15-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"key20220527094434_b16-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/ijc.25440","article-title":"Mesenchymal stem cells enhance growth and metastasis of colon cancer","volume":"127","author":"Shinagawa","year":"2010","journal-title":"Int J Cancer"},{"key":"key20220527094434_b17-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/scd.2007.0181","article-title":"Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo","volume":"17","author":"Yu","year":"2008","journal-title":"Stem Cells Dev"},{"key":"key20220527094434_b18-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.276.5309.111","article-title":"The receptor for the cytotoxic ligand TRAIL","volume":"276","author":"Pan","year":"1997","journal-title":"Science"},{"key":"key20220527094434_b19-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.critrevonc.2019.08.008","article-title":"The TRAIL to cancer therapy: Hindrances and potential solutions","volume":"143","author":"Wong","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20220527094434_b20-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cytogfr.2006.07.002","article-title":"Cytokines in breast cancer","volume":"17","author":"Nicolini","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20220527094434_b21-mmr-25-06-12722","first-page":"3603","article-title":"Bone marrow-derived mesenchymal stem cells as vehicles for interferon-\u03b2 delivery into tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res"},{"key":"key20220527094434_b22-mmr-25-06-12722","first-page":"812","article-title":"How desirable and undesirable features of na\u00efve or genetically reengineered mesenchymal stem cells are being considered in preclinical or clinical assays","volume":"22","author":"Gonzalez-Villarreal","year":"2017","journal-title":"J BUON"},{"key":"key20220527094434_b23-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1371\/journal.pone.0010611","article-title":"Systematic comparison of constitutive promoters and the doxycycline-inducible promoter","volume":"5","author":"Qin","year":"2010","journal-title":"PLoS One"},{"key":"key20220527094434_b24-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.bbrc.2004.07.046","article-title":"The secretable form of trimeric TRAIL, a potent inducer of apoptosis","volume":"321","author":"Kim","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20220527094434_b25-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1021\/mp300261e","article-title":"Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: A double-target therapy against non-Hodgkin's lymphoma","volume":"10","author":"Yan","year":"2013","journal-title":"Mol Pharm"},{"key":"key20220527094434_b26-mmr-25-06-12722","first-page":"19","article-title":"Improving mammalian cell factories: The selection of signal peptide has a major impact on recombinant protein synthesis and secretion in mammalian cells","volume":"10","author":"Stern","year":"2007","journal-title":"Trends Cell Mol Biol"},{"key":"key20220527094434_b27-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jcyt.2015.03.603","article-title":"Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy","volume":"17","author":"Yuan","year":"2015","journal-title":"Cytotherapy"},{"key":"key20220527094434_b28-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of facial expressions of pain in the laboratory mouse","volume":"7","author":"Langford","year":"2010","journal-title":"Nat Methods"},{"key":"key20220527094434_b29-mmr-25-06-12722","first-page":"99","volume-title":"Laboratory Animal Managent Rodents","author":"Committee on Rodents, Institute of Laboratory Animal Resources, Commission on Life Sciences and the National Research Council","year":"1996"},{"key":"key20220527094434_b30-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S1471-4906(01)01943-3","article-title":"Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies","volume":"22","author":"Bankert","year":"2001","journal-title":"Trends Immunol"},{"key":"key20220527094434_b31-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1097\/CCM.0b013e3182227550","article-title":"Murine models in critical care research","volume":"39","author":"Haouzi","year":"2011","journal-title":"Crit Care Med"},{"key":"key20220527094434_b32-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrc2192","article-title":"Maximizing mouse cancer models","volume":"7","author":"Frese","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20220527094434_b33-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"975871","DOI":"10.1155\/2012\/975871","article-title":"Markers for characterization of bone marrow multipotential stromal cells","volume":"2012","author":"Boxall","year":"2012","journal-title":"Stem Cells Int"},{"key":"key20220527094434_b34-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.5966\/sctm.2015-0190","article-title":"Identification and characterization of human endometrial mesenchymal stem\/stromal cells and their potential for cellular therapy","volume":"5","author":"Darzi","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"key20220527094434_b35-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"637239","DOI":"10.3389\/fcell.2021.637239","article-title":"CD73+ Mesenchymal stem cells ameliorate myocardial infarction by promoting angiogenesis","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"key20220527094434_b36-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/ijmm.2015.2191","article-title":"Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia\/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant","volume":"36","author":"Song","year":"2015","journal-title":"Int J Mol Med"},{"key":"key20220527094434_b37-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"e11140","DOI":"10.1371\/journal.pone.0011140","article-title":"Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts","volume":"5","author":"Secchiero","year":"2010","journal-title":"PLoS One"},{"key":"key20220527094434_b38-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cytogfr.2014.07.014","article-title":"TGF\u03b2 in T cell biology and tumor immunity: Angel or devil?","volume":"25","author":"Tu","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20220527094434_b39-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.trecan.2016.10.010","article-title":"B lymphocytes and cancer: A love-hate relationship","volume":"2","author":"Yuen","year":"2017","journal-title":"Trends Cancer"},{"key":"key20220527094434_b40-mmr-25-06-12722","first-page":"1777","article-title":"p53 Antibodies in the sera of patients with various types of cancer: A review","volume":"60","author":"Soussi","year":"2000","journal-title":"Cancer Res"},{"key":"key20220527094434_b41-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","article-title":"B cells, plasma cells and antibody repertoires in the tumour microenvironment","volume":"20","author":"Sharonov","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"key20220527094434_b42-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4161\/cbt.4.7.1767","article-title":"AKT activation and response to interferon-\u03b2 in human cancer cells","volume":"4","author":"Lei","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"key20220527094434_b43-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/gt.2008.101","article-title":"Cancer gene therapy using mesenchymal stem cells expressing interferon-\u03b2 in a mouse prostate cancer lung metastasis model","volume":"15","author":"Ren","year":"2008","journal-title":"Gene Ther"},{"key":"key20220527094434_b44-mmr-25-06-12722","first-page":"872","article-title":"Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta","volume":"59","author":"Dong","year":"1999","journal-title":"Cancer Res"},{"key":"key20220527094434_b45-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","article-title":"Interferons and their actions","volume":"56","author":"Pestka","year":"1987","journal-title":"Ann Rev Biochem"},{"key":"key20220527094434_b46-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/jir.1997.17.355","article-title":"Interferon-beta induces S phase accumulation selectively in human transformed cells","volume":"17","author":"Qin","year":"1997","journal-title":"J Interf Cytokine Res"},{"key":"key20220527094434_b47-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cytogfr.2016.03.013","article-title":"IFN-\u03b2 differentially regulates the function of T cell subsets in MS and EAE","volume":"30","author":"Kavrochorianou","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20220527094434_b48-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.4049\/jimmunol.177.6.3542","article-title":"IFN-\u03b2 Inhibits T cell activation capacity of central nervous system APCs","volume":"177","author":"Teige","year":"2006","journal-title":"J Immunol"},{"key":"key20220527094434_b49-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.18632\/oncotarget.24479","article-title":"Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAIL-signaling pathway","volume":"9","author":"Makowska","year":"2018","journal-title":"Oncotarget"},{"key":"key20220527094434_b50-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1038\/sj.onc.1208403","article-title":"TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-\u03b2 in cervical carcinoma cells","volume":"24","author":"Vannucchi","year":"2005","journal-title":"Oncogene"},{"key":"key20220527094434_b51-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1182\/blood-2017-09-808816","article-title":"TRAIL mediates and sustains constitutive NF-kB activation in LGL leukemia","volume":"131","author":"Yang","year":"2018","journal-title":"Blood"},{"key":"key20220527094434_b52-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"32208","DOI":"10.1074\/jbc.M000482200","article-title":"The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation","volume":"275","author":"M\u00fchlenbeck","year":"2000","journal-title":"J Biol Chem"},{"key":"key20220527094434_b53-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1128\/MCB.19.9.5923","article-title":"NF-\u03baB induces expression of the Bcl-2 homologue A1\/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis","volume":"19","author":"Wang","year":"1999","journal-title":"Mol Cell Biol"},{"key":"key20220527094434_b54-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.4049\/jimmunol.167.6.3164","article-title":"Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression","volume":"167","author":"Baetu","year":"2001","journal-title":"J Immunol"},{"key":"key20220527094434_b55-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1020031023947","article-title":"Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines","volume":"7","author":"Shetty","year":"2002","journal-title":"Apoptosis"},{"key":"key20220527094434_b56-mmr-25-06-12722","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4049\/jimmunol.163.2.920","article-title":"IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression","volume":"163","author":"Sedger","year":"1999","journal-title":"J Immunol"},{"key":"key20220527094434_b57-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1006\/excr.2000.5073","article-title":"P53-independent upregulation of KILLER\/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma","volume":"262","author":"Meng","year":"2001","journal-title":"Exp Cell Res"},{"key":"key20220527094434_b58-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/sj.onc.1206139","article-title":"Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation","volume":"22","author":"Shigeno","year":"2003","journal-title":"Oncogene"},{"key":"key20220527094434_b59-mmr-25-06-12722","first-page":"5299","article-title":"Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells","volume":"63","author":"Choi","year":"2003","journal-title":"Cancer Res"},{"key":"key20220527094434_b60-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1089\/scd.2012.0060","article-title":"Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer","volume":"21","author":"Bao","year":"2012","journal-title":"Stem Cells Dev"},{"key":"key20220527094434_b61-mmr-25-06-12722","first-page":"100017","article-title":"Immunomodulatory potential of mesenchymal stem cell role in diseases and therapies: A bioengineering prospective","volume":"4","author":"Taraballi","year":"2019","journal-title":"J Immunol Regen Med"},{"key":"key20220527094434_b62-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","article-title":"The Dark side of fibroblasts: Cancer-Associated fibroblasts as mediators of immunosuppression in the tumor microenvironment","volume":"10","author":"Monteran","year":"2019","journal-title":"Front Immunol"},{"key":"key20220527094434_b63-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/labinvest.3700389","article-title":"Tumor-infiltrating T lymphocytes: Friends or foes?","volume":"86","author":"Yu","year":"2006","journal-title":"Lab Investig"},{"key":"key20220527094434_b64-mmr-25-06-12722","doi-asserted-by":"publisher","first-page":"103753","DOI":"10.1016\/j.cellimm.2018.01.013","article-title":"Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?","volume":"343","author":"Badalamenti","year":"2019","journal-title":"Cell Immunol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:41Z","timestamp":1675468841000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2022.12722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,4,29]]}},"URL":"https:\/\/doi.org\/10.3892\/mmr.2022.12722","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"article-number":"206"}}